AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS
Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer's Clinical Trial at 2nd NovaScan Location Planned for Tampa
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
Pet Valu Announces Election of Directors
Pet Valu Holdings Ltd. (PET:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Pet Valu Holdings Ltd. (PET:CA) Q1 2026 Earnings Call Transcript
Pet Valu Reports First Quarter 2026 Results
Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis
Pet Valu Announces Timing of First Quarter 2026 Earnings Release and Annual General Meeting of Shareholders
Algernon Health highlights NovaScan brand for dedicated brain PET scanning centers
Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers
Algernon Health to open brain-focused PET scanning clinic in Florida
Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building
Origin Announces HP Embalagens as Strategic Distributor for Sustainable PET Bottlecaps
Telix Pharmaceuticals Limited (TLX) Discusses Physician Perspectives on Innovations in PSMA PET CT Imaging for Prostate Cancer Transcript
Pet Valu Holdings Ltd. (PET:CA) Q4 2025 Earnings Call Transcript
Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging
Origin Materials and Matrix Bottling Group Announce Partnership to Bring Recyclable PET Bottlecaps to Major Beverage Brands
Pet Valu Announces Timing of Fourth Quarter 2025 Earnings Release
Pet Valu (TSE:PET) Shares Down 0.7% – What’s Next?
Pet Valu Holdings Ltd. (TSE:PET) Given Consensus Rating of “Buy” by Brokerages
CARBIOS and Wankai New Materials sign the definitive agreement establishing a strategic partnership to the large-scale deployment of CARBIOS's PET biorecycling technology in Asia
Pet Valu Holdings Ltd. Announces Renewal of Normal Course Issuer Bid
CARBIOS signs two new multi-year commercial agreements for recycled PET with major players in the beverage industry
Algernon Health secures key investment and partners for PET rollout
Algernon Health strikes US neuroimaging deal with AMI, closes first tranche of private placement
Top Toy Brand LITTLEST PET SHOP Signs Global YouTube Sensation
Pet Valu Holdings Ltd. (PET:CA) Q3 2025 Earnings Call Transcript
First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune's ACI-19626 in Precision Medicine
ASP Isotopes Provides Business Updates
Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer's Detection
CARBIOS presents its 2025 half-year results and confirms its objective to build a PET biorecycling plant, with a revised timeline.
Contineum Therapeutics Reports Positive Topline Data From Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
Wag! Group Co. Successfully Completes Pre-Packaged Chapter 11 Plan of Reorganization
First Origin PET Caps in Stores with Power Hydration Pilot Launch
Eurazeo Enters Into Exclusive Discussions With INSPIRED PET NUTRITION Regarding the Sale of Its Stake in Ultra Premium Direct
Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients
Origin Materials Announces Strategic Customer Relationship with Berlin Packaging for Sustainable PET Bottlecaps
Pet Valu Reports Second Quarter 2025 Results
Origin Materials and Hordijk to Mass Produce PET Bottlecaps
CARBIOS enters the r-PET market for tire textile filaments
Wag! Group Co. Announces Recapitalization Transaction with Retriever LLC
Pet Valu Announces Timing of Second Quarter 2025 Earnings Release
Contineum Therapeutics Provides Update on Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791
FDA Approves Expanded Indications for GE HealthCare's Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer's Patients